Skip to content

Safety, Tolerability and Efficacy Evaluation of Colic Relief Stomach Roll-on

Safety, Tolerability and Efficacy Evaluation of Colic Relief Stomach Roll-on in Improving/Reliving Symptoms of Colic, Indigestion and Constipation in Newborns and Infants - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105403
Enrollment
50
Registered
2026-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R681- Nonspecific symptoms peculiar to infancy

Interventions

None listed

Sponsors

Mother Sparsh Baby Care Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects between the age group of 1st week to 1 year (of both genders). 2. Recurrent and prolonged periods of crying, fussing, or irritability reported by caregivers associated with colic discomfort as per parental judgement. 3. Subjects with specific FLACC score. 4. Subjects with specific IGSQ score. 5. Parents or guardians willing to let their new born or infants participate in this trial and sign a written consent form before the trial begins.

Exclusion criteria

Exclusion criteria: 1. Subjects above 1 year of age. 2. Subjects with chronic colic discomfort, abdominal colic necessitating emergency intervention, excretory system disorders, known congenital or metabolic anomalies or any chronic illness, allergies necessitating medications which can impact the study or subject judged by the investigator to be inappropriate for this trial. 3. Subjects receiving formula for specific medical purposes. 4. Subjects not willing to stop the use of other tummy oil or any medication for this indication during study period. 5. Subjects whose parents or guardians hesitant to sign the informed consent form or abiding by the study protocol.

Design outcomes

Primary

MeasureTime frame
Mean change in the discomfort intensity, indigestion, constipation/loose stools, episodes of colic in a day and crying duration.Timepoint: Baseline, 30 minutes, 1 hour, 3 hours, 24 hours, Day 3

Secondary

MeasureTime frame
Mean change in the discomfort irritation/reactions as per investigator s assessment of parent s observations.Timepoint: Baseline, 30 minutes, 1 hours, 3 hours, 24 hours, Day 3;Mean change in episodes of sleep interruption in 24 hrs as per investigator s assessment of parent s observations.Timepoint: Baseline, 30 minutes, 1 hours, 3 hours, 24 hours, Day 3;Mean change in duration for expelling gas/stool as per investigator s assessment of parent s observations.Timepoint: Baseline, 30 minutes, 1 hours, 3 hours, 24 hours, Day 3;Mean change in quality of life as per investigator s assessment of parent s observations.Timepoint: Baseline, 30 minutes, 1 hours, 3 hours, 24 hours, Day 3

Countries

India

Contacts

Public ContactJestin V Thomas

Leads Clinical Research and Bio Services Pvt. Ltd.

jestin.leadsclinbio@gmail.com9845125293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026